GNH USA

USA — NDC

Zoryve 0.3 %

GNH USA supplies Zoryve 0.3% cream (Roflumilast), a phosphodiesterase-4 inhibitor for plaque psoriasis and other skin conditions.

Roflumilast
ZORYVE
CREAM
0.3 %

Request sourcing

1
Pack/s

What is Roflumilast?

Roflumilast, the active ingredient in Zoryve 0.3% cream, is a phosphodiesterase-4 (PDE-4) inhibitor presented as a 0.3% cream for topical use. It is used to treat plaque psoriasis in adults and children 12 years of age and older, as well as other skin conditions such as seborrheic dermatitis and atopic dermatitis. GNH USA supplies Zoryve 0.3% cream as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Zoryve 0.3% cream is specifically formulated to target inflammatory skin conditions, providing relief and improving skin health. The cream is designed for once-daily application, making it a convenient option for patients managing these chronic skin conditions.

What is Roflumilast used for?

Zoryve 0.3% cream is a topical medication used to manage inflammatory skin conditions. It is primarily indicated for the following conditions:

- Plaque psoriasis: Reduces inflammation and symptoms associated with plaque psoriasis in adults and children 12 years of age and older. - Seborrheic dermatitis: Helps manage symptoms of seborrheic dermatitis in individuals 9 years of age and older. - Atopic dermatitis (eczema): Treats mild to moderate atopic dermatitis in patients 6 years of age and older.

What are the side effects of Roflumilast?

Zoryve 0.3% cream may cause several side effects, ranging from common to serious or rare. Common Side Effects: - Headache: A frequent side effect reported by users of the cream. - Diarrhea: Some patients may experience gastrointestinal discomfort. - Nausea: Mild to moderate nausea can occur. - Trouble sleeping: Difficulty sleeping has been reported by some users. - Application site pain: Discomfort or pain at the site of application is possible. - Upper respiratory tract infections: Some users may experience cold-like symptoms. - Urinary tract infections (UTIs): Infections of the urinary tract have been reported.

Serious or Rare Side Effects: - Bladder pain: Pain in the bladder area may occur. - Bloody or cloudy urine: Indicative of a potential urinary tract infection. - Difficult, burning, or painful urination: May signal a more serious infection. - Frequent urge to urinate: Could be a sign of a urinary tract issue.

What precautions apply to Roflumilast?

Zoryve 0.3% cream should be used with caution and under the guidance of a healthcare provider. Important precautions include: - Liver function: Patients with decreased liver function should discuss the use of this medication with their doctor, as it may build up in the body and cause side effects. - Allergies: Inform your healthcare provider if you are allergic to roflumilast or any of the ingredients in the cream. - Pregnancy: This medication should not be used during pregnancy unless the benefits outweigh the risks. Consult your doctor immediately if you become pregnant while using this medication. - Children: The safety and effectiveness of this medication for plaque psoriasis have not been established for children under 12 years of age. For seborrheic dermatitis, it is not recommended for children under 9 years of age, and for atopic dermatitis, it is not recommended for children under 6 years of age. - Application: Do not use Zoryve in or on your eyes, mouth, or vagina. Avoid contact with these areas. - Store at room temperature: Protect the medication from light and moisture, and keep it out of the reach of children.

What does Roflumilast interact with?

Zoryve 0.3% cream may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major Interactions (Avoid): - Moderate to severe liver impairment: Patients with moderate to severe liver impairment should not use Zoryve cream. - Allergy to roflumilast: Avoid using the medication if you are allergic to roflumilast or any of its ingredients.

Moderate Interactions (Monitor Closely): - Other topical medications: Inform your healthcare provider about all topical medications you are using to avoid potential interactions. - Systemic medications: Discuss all systemic medications you are taking with your healthcare provider to ensure safe use of Zoryve cream. - Pregnancy and breastfeeding: Consult your healthcare provider before using this medication if you are pregnant or breastfeeding.

Frequently asked questions

What is Zoryve 0.3% cream used for?+
Zoryve 0.3% cream is a topical medication used to treat plaque psoriasis in adults and children 12 years of age and older. It is also used to manage seborrheic dermatitis in individuals 9 years of age and older, and mild to moderate atopic dermatitis in patients 6 years of age and older. The cream helps reduce inflammation and improve symptoms associated with these skin conditions.
How does roflumilast work?+
Roflumilast, the active ingredient in Zoryve 0.3% cream, works by selectively inhibiting phosphodiesterase-4 (PDE4). This inhibition leads to increased levels of cyclic adenosine monophosphate (cAMP) within cells, which reduces the production of inflammatory cytokines. By targeting this pathway, roflumilast helps to decrease inflammation and improve symptoms associated with various skin conditions.
What is the usual dose of Zoryve 0.3% cream?+
The usual dose of Zoryve 0.3% cream is applied once daily to the affected areas of the skin. The exact dosage and duration of treatment should be determined by a healthcare provider based on the patient's specific needs and response to the medication.
Is Zoryve 0.3% cream safe during pregnancy or breastfeeding?+
Zoryve 0.3% cream should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while using this medication, contact your doctor immediately. For breastfeeding, consult your healthcare provider to discuss the potential risks and benefits before using the cream.
How do I order Zoryve 0.3% cream from GNH USA?+
To order Zoryve 0.3% cream from GNH USA, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the necessary import paperwork.
How does Zoryve 0.3% cream compare to other treatments for plaque psoriasis?+
Zoryve 0.3% cream is a topical medication specifically formulated to target inflammation associated with plaque psoriasis. Compared to other treatments, it offers a convenient once-daily application and is designed to be effective for both adults and children. However, the choice of treatment should be made in consultation with a healthcare provider based on individual patient needs and response to therapy.
How should Zoryve 0.3% cream be stored and handled?+
Zoryve 0.3% cream should be stored at room temperature, protected from light and moisture, and kept out of the reach of children. Ensure the medication is stored in its original packaging to maintain its stability and efficacy. Avoid exposing the cream to extreme temperatures or direct sunlight.
How is Zoryve 0.3% cream administered?+
Zoryve 0.3% cream is applied topically to the affected areas of the skin once daily. The cream should be rubbed in well, and hands should be washed with soap and water after application, unless you are treating areas of your hands. Avoid contact with eyes, mouth, or vaginal areas.
What are the most serious risks to watch for when using Zoryve 0.3% cream?+
While using Zoryve 0.3% cream, watch for serious side effects such as bladder pain, bloody or cloudy urine, difficult or painful urination, and frequent urge to urinate. These symptoms could indicate a more serious condition and should be reported to a healthcare provider immediately.
Who should not use Zoryve 0.3% cream?+
Zoryve 0.3% cream should not be used by individuals with moderate to severe liver impairment or those who are allergic to roflumilast or any of the ingredients in the cream. It is also not recommended for children under 12 years of age for plaque psoriasis, under 9 years of age for seborrheic dermatitis, and under 6 years of age for atopic dermatitis. Always consult a healthcare provider before starting any new medication.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Roflumilast
Brand
ZORYVE
Strength
0.3 %
Form
CREAM
Route
TOPICAL
Manufacturer
ARCUTIS CANADA, INC.
Origin
CANADA

Related products